{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:36:42Z","timestamp":1786707402948,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"2022 Nantong Science and Technology Project","award":["Project number: JC22022017"],"award-info":[{"award-number":["Project number: JC22022017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Genom"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s13258-025-01724-w","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T09:04:44Z","timestamp":1768381484000},"page":"1101-1116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TSTA3 promotes the malignant progression of bladder cancer by regulating LAMP2 and MAPK signaling pathway-mediated epithelial-mesenchymal transition"],"prefix":"10.1007","volume":"48","author":[{"given":"Nihao","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3886-0868","authenticated-orcid":false,"given":"Fei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"issue":"4","key":"1724_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/j.seminoncol.2017.10.013","volume":"44","author":"F Alessandrini","year":"2017","unstructured":"Alessandrini F, Pezze L, Ciribilli Y (2017) LAMPs: shedding light on cancer biology. Semin Oncol 44(4):239\u2013253. https:\/\/doi.org\/10.1053\/j.seminoncol.2017.10.013","journal-title":"Semin Oncol"},{"key":"1724_CR2","doi-asserted-by":"publisher","first-page":"119499","DOI":"10.1016\/j.lfs.2021.119499","volume":"278","author":"ER Asl","year":"2021","unstructured":"Asl ER, Amini M, Najafi S, Mansoori B, Mokhtarzadeh A, Mohammadi A, Lotfinejad P, Bagheri M, Shirjang S, Lotfi Z, Rasmi Y, Baradaran B (2021) Interplay between MAPK\/ERK signaling pathway and micrornas: a crucial mechanism regulating cancer cell metabolism and tumor progression. Life Sci 278:119499. https:\/\/doi.org\/10.1016\/j.lfs.2021.119499","journal-title":"Life Sci"},{"issue":"9","key":"1724_CR3","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1042\/BCJ20210083","volume":"478","author":"Y Bernardi","year":"2021","unstructured":"Bernardi Y, Strobl-Mazzulla PH (2021) What we can learn from embryos to understand the mesenchymal-to-epithelial transition in tumor progression. Biochem J 478(9):1809\u20131825. https:\/\/doi.org\/10.1042\/BCJ20210083","journal-title":"Biochem J"},{"issue":"10364","key":"1724_CR4","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","volume":"400","author":"E Comperat","year":"2022","unstructured":"Comperat E, Amin MB, Cathomas R, Choudhury A, De Santis M, Kamat A, Stenzl A, Thoeny HC, Witjes JA (2022) Current best practice for bladder cancer: a narrative review of diagnostics and treatments. Lancet 400(10364):1712\u20131721. https:\/\/doi.org\/10.1016\/S0140-6736(22)01188-6","journal-title":"Lancet"},{"issue":"15","key":"1724_CR5","doi-asserted-by":"publisher","first-page":"19395","DOI":"10.18632\/oncotarget.6283","volume":"7","author":"JC de Freitas Junior","year":"2016","unstructured":"de Freitas Junior JC, Morgado-Diaz JA (2016) The role of N-glycans in colorectal cancer progression: potential biomarkers and therapeutic applications. Oncotarget 7(15):19395\u201319413. https:\/\/doi.org\/10.18632\/oncotarget.6283","journal-title":"Oncotarget"},{"key":"1724_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57080749","author":"J Dobruch","year":"2021","unstructured":"Dobruch J, Oszczudlowski M (2021) Bladder cancer: current challenges and future directions. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina57080749","journal-title":"Medicina (Kaunas)"},{"key":"1724_CR7","doi-asserted-by":"publisher","first-page":"109896","DOI":"10.1016\/j.abb.2024.109896","volume":"754","author":"W Dong","year":"2024","unstructured":"Dong W, Li X, Cheng L, Yang J, Zhao Z, Qiang X, Li P, Wu J, Guo L (2024) RAE1 promotes gastric carcinogenesis and epithelial-mesenchymal transition. Arch Biochem Biophys 754:109896. https:\/\/doi.org\/10.1016\/j.abb.2024.109896","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"1724_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskjot","year":"2023","unstructured":"Dyrskjot L, Hansel DE, Efstathiou JA, Knowles MA, Galsky MD, Teoh J, Theodorescu D (2023) Bladder cancer. Nat Rev Dis Primers 9(1):58. https:\/\/doi.org\/10.1038\/s41572-023-00468-9","journal-title":"Nat Rev Dis Primers"},{"key":"1724_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020800","author":"M Fedele","year":"2022","unstructured":"Fedele M, Sgarra R, Battista S, Cerchia L, Manfioletti G (2022) The epithelial-mesenchymal transition at the crossroads between metabolism and tumor progression. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23020800","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1724_CR10","doi-asserted-by":"publisher","first-page":"20073","DOI":"10.3390\/molecules191220073","volume":"19","author":"J Guo","year":"2014","unstructured":"Guo J, Li X, Tan Z, Lu W, Yang G, Guan F (2014) Alteration of N-glycans and expression of their related glycogenes in the epithelial-mesenchymal transition of HCV29 bladder epithelial cells. Molecules 19(12):20073\u201320090. https:\/\/doi.org\/10.3390\/molecules191220073","journal-title":"Molecules"},{"key":"1724_CR11","doi-asserted-by":"publisher","first-page":"1138483","DOI":"10.3389\/fimmu.2023.1138483","volume":"14","author":"X Guo","year":"2023","unstructured":"Guo X, Chen S, Wang X, Liu X (2023a) Immune-related pulmonary toxicities of checkpoint inhibitors in non-small cell lung cancer: Diagnosis, mechanism, and treatment strategies. Front Immunol 14:1138483. https:\/\/doi.org\/10.3389\/fimmu.2023.1138483","journal-title":"Front Immunol"},{"issue":"1","key":"1724_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12935-023-03109-z","volume":"23","author":"Y Guo","year":"2023","unstructured":"Guo Y, Hao Y, Shen L, Du Y, Wang X, Gao L, Feng X, Zhai Y, Liu Z, Xu E, Yang Y, Xi Y, Yang B, Zhang L (2023b) TSTA3 overexpression promotes malignant characteristics in LUSC by regulating LAMP2-mediated autophagy and tumor microenvironment. Cancer Cell Int 23(1):285. https:\/\/doi.org\/10.1186\/s12935-023-03109-z","journal-title":"Cancer Cell Int"},{"issue":"3","key":"1724_CR15","first-page":"1210","volume":"24","author":"Z Huang","year":"2019","unstructured":"Huang Z, Liu G (2019) Research on correlations of MiR-203 expression with onset and prognosis of bladder cancer. J BUON 24(3):1210\u20131218","journal-title":"J BUON"},{"issue":"3","key":"1724_CR13","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1080\/21655979.2022.2039485","volume":"13","author":"H Huang","year":"2022","unstructured":"Huang H, He Y, Li Y, Gu M, Wu M, Ji L (2022) Eriodictyol suppresses the malignant progression of colorectal cancer by downregulating tissue specific transplantation antigen P35B (TSTA3) expression to restrain fucosylation. Bioengineered 13(3):5551\u20135563. https:\/\/doi.org\/10.1080\/21655979.2022.2039485","journal-title":"Bioengineered"},{"key":"1724_CR14","doi-asserted-by":"publisher","first-page":"1537808","DOI":"10.3389\/fimmu.2025.1537808","volume":"16","author":"P Huang","year":"2025","unstructured":"Huang P, Wang J, Yu Z, Lu J, Sun Z, Chen Z (2025) Redefining bladder cancer treatment: innovations in overcoming drug resistance and immune evasion. Front Immunol 16:1537808. https:\/\/doi.org\/10.3389\/fimmu.2025.1537808","journal-title":"Front Immunol"},{"key":"1724_CR16","doi-asserted-by":"publisher","first-page":"154536","DOI":"10.1016\/j.prp.2023.154536","volume":"247","author":"LJ Jiang","year":"2023","unstructured":"Jiang LJ, Guo SB, Huang ZY, Li XL, Jin XH, Huang WJ, Tian XP (2023) PHB promotes bladder cancer cell epithelial-mesenchymal transition via the Wnt\/beta-catenin signaling pathway. Pathol Res Pract 247:154536. https:\/\/doi.org\/10.1016\/j.prp.2023.154536","journal-title":"Pathol Res Pract"},{"key":"1724_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22137201","author":"IH Kim","year":"2021","unstructured":"Kim IH, Lee HJ (2021) Perioperative systemic treatment for muscle-invasive bladder cancer: current evidence and future perspectives. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22137201","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1724_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5603\/FHC.a2022.0031","volume":"60","author":"MW Leal Quirino","year":"2022","unstructured":"Leal Quirino MW, Albuquerque APB, de Souza MFD, Filho A, Martins MR, Pitta M, Pereira MC, de Melo MJB (2022) FUCA2 and TSTA3 expression in gastric cancer: candidate biomarkers of malignant transformation. Folia Histochem Cytobiol 60(4):335\u2013343. https:\/\/doi.org\/10.5603\/FHC.a2022.0031","journal-title":"Folia Histochem Cytobiol"},{"issue":"2","key":"1724_CR19","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.3892\/ol.2020.11741","volume":"20","author":"S Lei","year":"2020","unstructured":"Lei S, Xu H, Chen N, Pan H, Xie W, He Y, Jin J (2020) MKP-1 overexpression is associated with chemoresistance in bladder cancer via the MAPK pathway. Oncol Lett 20(2):1743\u20131751. https:\/\/doi.org\/10.3892\/ol.2020.11741","journal-title":"Oncol Lett"},{"issue":"7","key":"1724_CR21","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41419-021-03963-7","volume":"12","author":"T Li","year":"2021","unstructured":"Li T, Tao Z, Zhu Y, Liu X, Wang L, Du Y, Cao J, Wang B, Zhang J, Hu X (2021) Exosomal Annexin A6 induces gemcitabine resistance by inhibiting ubiquitination and degradation of EGFR in triple-negative breast cancer. Cell Death Dis 12(7):684. https:\/\/doi.org\/10.1038\/s41419-021-03963-7","journal-title":"Cell Death Dis"},{"key":"1724_CR20","doi-asserted-by":"publisher","first-page":"101059","DOI":"10.1016\/j.drup.2024.101059","volume":"73","author":"F Li","year":"2024","unstructured":"Li F, Zhang H, Huang Y, Li D, Zheng Z, Xie K, Cao C, Wang Q, Zhao X, Huang Z, Chen S, Chen H, Fan Q, Deng F, Hou L, Deng X, Tan W (2024) Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer. Drug Resist Updat 73:101059. https:\/\/doi.org\/10.1016\/j.drup.2024.101059","journal-title":"Drug Resist Updat"},{"key":"1724_CR22","doi-asserted-by":"publisher","first-page":"884448","DOI":"10.3389\/fonc.2022.884448","volume":"12","author":"SP Liu","year":"2022","unstructured":"Liu SP, Li XM, Liu DM, Xie SH, Zhang SB, Li Y, Xie ZF (2022) LAMP2 as a biomarker related to prognosis and immune infiltration in esophageal cancer and other cancers: a comprehensive Pan-Cancer analysis. Front Oncol 12:884448. https:\/\/doi.org\/10.3389\/fonc.2022.884448","journal-title":"Front Oncol"},{"issue":"2","key":"1724_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3892\/ijo.2019.4953","volume":"56","author":"S Park","year":"2020","unstructured":"Park S, Lim JM, Chun JN, Lee S, Kim TM, Kim DW, Kim SY, Bae DJ, Bae SM, So I, Kim HG, Choi JY, Jeon JH (2020) Altered expression of fucosylation pathway genes is associated with poor prognosis and tumor metastasis in non\u2013small cell lung cancer. Int J Oncol 56(2):559\u2013567. https:\/\/doi.org\/10.3892\/ijo.2019.4953","journal-title":"Int J Oncol"},{"issue":"5","key":"1724_CR24","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel VG, Oh WK, Galsky MD (2020) Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J Clin 70(5):404\u2013423. https:\/\/doi.org\/10.3322\/caac.21631","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1724_CR25","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1080\/15548627.2022.2074105","volume":"19","author":"PM Rodrigues","year":"2023","unstructured":"Rodrigues PM, Sousa LG, Perrod C, Maceiras AR, Ferreirinha P, Pombinho R, Romera-Cardenas G, Gomez-Lazaro M, Senkara M, Pistolic J, Cabanes D, Klein L, Saftig P, Alves NL (2023) LAMP2 regulates autophagy in the thymic epithelium and thymic stroma-dependent CD4 T cell development. Autophagy 19(2):426\u2013439. https:\/\/doi.org\/10.1080\/15548627.2022.2074105","journal-title":"Autophagy"},{"key":"1724_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/978-3-031-27156-4_10","volume":"185","author":"RF Saeed","year":"2023","unstructured":"Saeed RF, Awan UA, Saeed S, Mumtaz S, Akhtar N, Aslam S (2023) Targeted therapy and personalized medicine. Cancer Treat Res 185:177\u2013205. https:\/\/doi.org\/10.1007\/978-3-031-27156-4_10","journal-title":"Cancer Treat Res"},{"key":"1724_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/genes14081539","author":"A Shalata","year":"2023","unstructured":"Shalata A, Bar-Shai M, Hadid Y, Mahroum M, Mintz H, Shalata ZE, Radzishevsky E, Genizi J, Lorber A, Ben-Yosef T, Yaniv L (2023) Danon disease: Entire LAMP2 gene deletion with unusual clinical presentation-case report and review of the literature. Genes (Basel). https:\/\/doi.org\/10.3390\/genes14081539","journal-title":"Genes (Basel)"},{"key":"1724_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113508","author":"F Song","year":"2022","unstructured":"Song F, Kotolloshi R, Gajda M, Holzer M, Grimm MO, Steinbach D (2022) Reduced IQGAP2 promotes bladder cancer through regulation of MAPK\/ERK pathway and cytokines. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232113508","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1724_CR29","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1002\/ijc.32311","volume":"145","author":"M Sun","year":"2019","unstructured":"Sun M, Zhao W, Chen Z, Li M, Li S, Wu B, Bu R (2019) Circular RNA CEP128 promotes bladder cancer progression by regulating Mir-145-5p\/Myd88 via MAPK signaling pathway. Int J Cancer 145(8):2170\u20132181. https:\/\/doi.org\/10.1002\/ijc.32311","journal-title":"Int J Cancer"},{"issue":"17","key":"1724_CR30","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1158\/1078-0432.CCR-20-4459","volume":"27","author":"M Taki","year":"2021","unstructured":"Taki M, Abiko K, Ukita M, Murakami R, Yamanoi K, Yamaguchi K, Hamanishi J, Baba T, Matsumura N, Mandai M (2021) Tumor immune microenvironment during Epithelial-Mesenchymal transition. Clin Cancer Res 27(17):4669\u20134679. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-4459","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1724_CR31","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","volume":"21","author":"L Tran","year":"2021","unstructured":"Tran L, Xiao JF, Agarwal N, Duex JE, Theodorescu D (2021) Advances in bladder cancer biology and therapy. Nat Rev Cancer 21(2):104\u2013121. https:\/\/doi.org\/10.1038\/s41568-020-00313-1","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"1724_CR32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s12026-012-8337-z","volume":"52","author":"L Wang","year":"2012","unstructured":"Wang L, Huang J, Jiang M, Lin H (2012) Tissue-specific transplantation antigen P35B (TSTA3) immune response-mediated metabolism coupling cell cycle to postreplication repair network in no-tumor hepatitis\/cirrhotic tissues (HBV or HCV infection) by biocomputation. Immunol Res 52(3):258\u2013268. https:\/\/doi.org\/10.1007\/s12026-012-8337-z","journal-title":"Immunol Res"},{"issue":"3","key":"1724_CR33","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1158\/2326-6066.CIR-20-0428","volume":"9","author":"L Wang","year":"2021","unstructured":"Wang L, Yu S, Chan ER, Chen KY, Liu C, Che D, Awadallah A, Myers J, Askew D, Huang AY, Maillard I, Huang D, Xin W, Zhou L (2021) Notch-Regulated dendritic cells restrain inflammation-associated colorectal carcinogenesis. Cancer Immunol Res 9(3):348\u2013361. https:\/\/doi.org\/10.1158\/2326-6066.CIR-20-0428","journal-title":"Cancer Immunol Res"},{"issue":"9","key":"1724_CR34","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1002\/1878-0261.13172","volume":"16","author":"Q Wang","year":"2022","unstructured":"Wang Q, Karvelsson ST, Johannsson F, Vilhjalmsson AI, Hagen L, de Miranda Fonseca D, Sharma A, Slupphaug G, Rolfsson O (2022) UDP-glucose dehydrogenase expression is upregulated following EMT and differentially affects intracellular Glycerophosphocholine and acetylaspartate levels in breast mesenchymal cell lines. Mol Oncol 16(9):1816\u20131840. https:\/\/doi.org\/10.1002\/1878-0261.13172","journal-title":"Mol Oncol"},{"issue":"8","key":"1724_CR35","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1080\/08820139.2022.2118606","volume":"51","author":"DF Ward Grados","year":"2022","unstructured":"Ward Grados DF, Ahmadi H, Griffith TS, Warlick CA (2022) Immunotherapy for bladder cancer: latest advances and ongoing clinical trials. Immunol Invest 51(8):2226\u20132251. https:\/\/doi.org\/10.1080\/08820139.2022.2118606","journal-title":"Immunol Invest"},{"issue":"4","key":"1724_CR36","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1080\/15548627.2019.1635380","volume":"16","author":"H Wu","year":"2020","unstructured":"Wu H, Liu C, Yang Q, Xin C, Du J, Sun F, Zhou L (2020) MIR145-3p promotes autophagy and enhances bortezomib sensitivity in multiple myeloma by targeting HDAC4. Autophagy 16(4):683\u2013697. https:\/\/doi.org\/10.1080\/15548627.2019.1635380","journal-title":"Autophagy"},{"issue":"24","key":"1724_CR37","doi-asserted-by":"publisher","first-page":"11339","DOI":"10.7150\/thno.48225","volume":"10","author":"L Zhang","year":"2020","unstructured":"Zhang L, Gao Y, Zhang X, Guo M, Yang J, Cui H, Kong P, Niu X, Bi Y, Xu J, Yan T, Ma Y, Yang J, Qian Y, Wang F, Li H, Liu F, Cheng X, Cui Y (2020) TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2. Theranostics 10(24):11339\u201311358. https:\/\/doi.org\/10.7150\/thno.48225","journal-title":"Theranostics"},{"issue":"3","key":"1724_CR38","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.1002\/jcb.27753","volume":"120","author":"J Zheng","year":"2019","unstructured":"Zheng J, Wang J, Jia Y, Liu T, Duan Y, Liang X, Liu L (2019) microRNA-211 promotes proliferation, migration, and invasion ability of oral squamous cell carcinoma cells via targeting the bridging integrator 1 protein. J Cell Biochem 120(3):4644\u20134653. https:\/\/doi.org\/10.1002\/jcb.27753","journal-title":"J Cell Biochem"}],"container-title":["Genes & Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-025-01724-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13258-025-01724-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-025-01724-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:09:50Z","timestamp":1786705790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13258-025-01724-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1724"],"URL":"https:\/\/doi.org\/10.1007\/s13258-025-01724-w","relation":{},"ISSN":["1976-9571","2092-9293"],"issn-type":[{"value":"1976-9571","type":"print"},{"value":"2092-9293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent after being fully informed of the study objectives. This study received approval from the Ethics Committee of Affiliated Haimen Hospital of Xinglin College, Nantong University and adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}